Chayama, Kazuaki

Publishing since 1985 (Dinosaur)

Has published 415 publications in 26 years

Number of publications published per year by Chayama, Kazuaki. (Source : PubMed)

Distribution of publications types for Chayama, Kazuaki. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Tsuge M, Noguchi C, Akiyama R, Matsushita M, Kunihiro K, Tanaka S, Abe H, Mitsui F, Kitamura S, Hatakeyama T, Kimura T, Miki D, Hiraga N, Imamura M, Takahashi S, Hayses CN, Chayama K. G to A hypermutation of TT virus.  Virus Res.  2010;149;2  
•  Oba S, Tanaka S, Oka S, Kanao H, Yoshida S, Shimamoto F, Chayama K. Characterization of colorectal tumors using narrow-band imaging magnification: combined diagnosis with both pit pattern and microvessel features.  Scand. J. Gastroenterol.  2010  
•  Tsuge M, Hiraga N, Akiyama R, Tanaka S, Matsushita M, Mitsui F, Abe H, Kitamura S, Hatakeyama T, Kimura T, Miki D, Mori N, Imamura M, Takahashi S, Hayes CN, Chayama K. HBx protein is indispensable for development of viremia in human hepatocyte chimeric mice.  J. Gen. Virol.  2010  
•  Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K. Natural Course of Lugol-Voiding Lesions in Patients with Superficial Esophageal Squamous Cell Carcinoma.  Digestion  2010;82;1  
•  Kamiya N, Iwao E, Hiraga N, Tsuge M, Imamura M, Takahashi S, Miyoshi S, Tateno C, Yoshizato K, Chayama K. Practical Evaluation of a Mouse with Chimeric Human Liver Model for Hepatitis C Virus Infection Using an NS3-4A Protease Inhibitor.  J. Gen. Virol.  2010  
•  Wada Y, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Relationship between Helicobacter pylori Tyrosine-Phosphorylated CagA-Related Markers and the Development of Diffuse-Type Gastric Cancers: A Case-Control Study.  Digestion  2010;82;1  
•  Fukuhara T, Hiyama T, Tanaka S, Oka S, Yoshihara M, Arihiro K, Chayama K. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.  J. Clin. Gastroenterol.  2010;44;2  
•  Kimura Y, Hyogo H, Yamagishi SI, Takeuchi M, Ishitobi T, Nabeshima Y, Arihiro K, Chayama K. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.  J. Gastroenterol.  2010  
•  Katamura Y, Aikata H, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Ishikawa M, Hieda M, Kakizawa H, Chayama K. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases.  J. Gastroenterol. Hepatol.  2010  
•  Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up.  J. Gastroenterol. Hepatol.  2010  

[ See timeline ] [ See all publications ]